Active LitigationMDL 3026
Toxic Baby Formula NEC Lawsuit Facts
TorHoerman Law is actively accepting claims for the Toxic Baby Formula NEC Lawsuit.
Active Litigation·MDL 3026
TorHoerman Law is actively accepting claims for the Toxic Baby Formula NEC Lawsuit.
On this page, we’ll discuss whether there is a Baby Formula NEC Class Action Lawsuit, how NEC Baby Formula Lawsuits are currently being handled, developments in the NEC Litigation, how experienced NEC Baby Formula Lawyers can help families, and much more.
NEC Baby Formula Lawsuits have been filed by parents of premature babies who were fed cow’s milk based formulas in the NICU or maternity ward and subsequently developed necrotizing enterocolitis (NEC).
Necrotizing enterocolitis (NEC) is a life-threatening gastric condition that impacts infants, particularly premature babies and low birth weight infants.
Parents have taken legal action against the manufacturers of toxic cow milk formula products.
Defendants named in the NEC Infant Formula Litigation include Abbott Laboratories and Mead Johnson.
Lawsuits filed against baby formula manufacturers have been consolidated into multidistrict litigation (MDL) and are also being pursued in state courts across the country.
MDL and these state court cases are different from class action lawsuits: each case is pursued based on each claimant’s respective damages.
Class action settlements, on the other hand, are distributed equally among all plaintiffs in the class.
Many law firms on the internet refer to the NEC Baby Formula MDL as the “NEC Class Action Lawsuit” or the “NEC Infant Formula Class Action MDL” even though these terms are incorrect.
The NEC Lawyers at TorHoerman Law are currently accepting new clients with NEC claims involving Enfamil products manufactured by Mead Johnson.
TorHoerman Law is no longer accepting NEC clients with claims against Similac.

If your child developed necrotizing enterocolitis (NEC) after being fed cow’s milk based formula in the maternity ward or NICU of a hospital, you may be eligible to file an NEC Baby Formula Lawsuit.
Contact a NEC Baby Formula Lawyer from TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the NEC Baby Formula Lawsuit instantly.
Necrotizing Enterocolitis (NEC) can have devastating effects on both a premature infant and their family, leading to severe medical complications, emotional distress, and financial burdens.
NEC Lawsuits are currently being handled in both state courts and multidistrict litigation (MDL), where families are seeking compensation from major baby formula manufacturers.
TorHoerman Law is currently accepting NEC claims involving Enfamil products manufactured by Mead Johnson, including claims involving serious injuries and long-term medical complications.
Reach out to our NEC Baby Formula Lawyers today for more information. We’re here to help you.
No, there is not an NEC Class Action Lawsuit.
The NEC Baby Formula Lawsuit is consolidated into multidistrict litigation (MDL) rather than through a class action.
State courts are also handling NEC Lawsuits individually and through smaller consolidations of several NEC cases.
Multidistrict litigation (MDL) allows for the consolidation of similar cases, making it easier to manage the pretrial process while still allowing each case to be handled on its own merits.
In the NEC Baby Formula MDL, cases are being pursued in federal court, where plaintiffs (typically parents of preterm infants) can individually present their claims and seek compensation based on the specific circumstances of their case.
This differs from a class action, where one lawsuit is filed on behalf of a group, and any settlement is divided equally among plaintiffs.
The MDL, consolidated in the United States District Court for the Northern District of Illinois, enables families to pursue justice and compensation tailored to the unique impact NEC has had on their baby and family.
While no class action has been filed, this approach ensures that victims receive compensation that reflects their individual damages, such as medical costs, pain and suffering, and long-term care needs.
In addition to the MDL, some families may also pursue their claims in state courts, depending on jurisdiction and individualized legal strategies.
As the litigation progresses, recent trial verdicts, such as the $495 million verdict obtained by TorHoerman Law against Abbott Laboratories, may influence settlement negotiations and provide guidance for future cases.

Families affected by NEC should consult an experienced lawyer to explore their legal options and understand how these cases are proceeding.
The NEC Lawyers at TorHoerman Law can help you through the legal process.
Reach out to us for a free consultation, or use the chatbot on this page to find out if you qualify for the NEC Baby Formula Lawsuit instantly.
It’s important that potential clients in the NEC Baby Formula Lawsuit understand how MDL differs from a class action lawsuit.
The NEC Baby Formula Lawsuits consolidated into the MDL consist of product liability claims made against Abbott Laboratories and Mead Johnson.
The claims made were from parents all over the country whose children fell victim to necrotizing enterocolitis (NEC).
In an MDL, settlements are distributed to claimants based on the facts of their individual case and damages.
Enfamil and Similac Baby Formula Lawsuits filed in the MDL would be compensated according to their unique situation.
If the NEC Infant Formula Lawsuit was filed as a class action lawsuit, settlements would be distributed evenly amongst all claimants, regardless of their individual situations and damages.
This means that even if a claimant’s premature baby passed away due to NEC, they would receive the same monetary compensation as a person whose child was much less effected.
This is a defining difference between MDL and class action lawsuits.
Some NEC lawsuits are pursued in state courts outside of the MDL due to differences in jurisdiction and individual case circumstances.
Plaintiffs may file in state courts if their claims are based on state-specific laws, such as product liability or negligence statutes that may provide different legal advantages.
In certain cases, plaintiffs may also prefer state courts because they believe the local legal environment or jury pool might be more favorable to their case.
Additionally, some state courts may offer quicker trial dates than the federal MDL, allowing for a more timely resolution.
The MDL process is primarily used to streamline pretrial proceedings in federal court, but it does not prevent plaintiffs from filing individual cases in their state.
This dual-track approach ensures that each case receives personalized attention based on the specific legal standards and facts involved.
TorHoerman Law is involved in several NEC Baby Formula Lawsuits filed in state courts.
For more information about this subject, please reach out to our NEC Lawyers.
In a landmark case, TorHoerman Law secured a $495 million verdict against Abbott Laboratories, the manufacturer of Similac baby formula.
This case, filed on behalf of Margo Gill and her daughter Robynn, highlighted the severe consequences of feeding cow’s milk-based formulas to vulnerable preemies.
The jury found that Abbott Laboratories had failed to adequately warn healthcare providers and parents about the risks associated with their products.
Of the total verdict, $95 million was awarded in compensatory damages, and $400 million in punitive damages, reflecting the severity of the company’s negligence.
This victory marks a significant milestone in ongoing NEC Baby Formula litigation, setting a powerful precedent for future cases.

TorHoerman Law’s success underscores its commitment to holding major corporations accountable for the harm caused by toxic products.
Our law firm continues to represent families in NEC litigation and is currently accepting new NEC clients with claims involving Enfamil products manufactured by Mead Johnson.
If your child developed NEC after consuming baby formula, contact TorHoerman Law for a free consultation.
Necrotizing enterocolitis (NEC) is a severe gastrointestinal disorder primarily affecting premature infants.
NEC leads to inflammation and death of intestinal tissue, which can cause severe complications like infection, intestinal perforation, and in the worst cases, death.
NEC typically develops within the first few weeks of life, especially in babies born before 37 weeks of gestation.
The exact cause of NEC is not fully understood, but it is often associated with a combination of factors, including premature birth, feeding practices, and bacterial infections in the intestines.

Infants who are fed cow’s milk-based formulas instead of breast milk are at a higher risk of developing NEC, as studies have shown that breast milk offers protective properties against intestinal inflammation.
The symptoms of NEC include abdominal swelling, bloody stools, vomiting, and lethargy.
Immediate medical intervention is crucial as untreated NEC can lead to life-threatening complications like sepsis and short bowel syndrome.
In severe cases, surgery may be required to remove the damaged sections of the intestines.
For families, the impact of NEC can be emotionally and financially overwhelming, as the cost of medical care is often high, and the long-term health consequences for the child can be profound.
NEC lawsuits have been filed against Abbott Laboratories, Mead Johnson, and other defendants over allegations involving cow’s milk-based formulas and the risk of NEC in premature infants.
TorHoerman Law is currently accepting new NEC clients with claims involving Enfamil products manufactured by Mead Johnson and is no longer accepting new clients with claims against Similac.
Infant formulas from Abbott (Similac) and Mead Johnson (Enfamil) are claimed to be toxic to premature infants due to their reliance on cow’s milk as the primary ingredient.
This base ingredient lacks the critical immune-boosting and digestive-supportive properties of human breast milk or donor milk, which is vital for preterm infants whose systems are underdeveloped.
Scientific studies have demonstrated that premature babies treated with cow’s milk formula feeding are significantly more likely to develop necrotizing enterocolitis (NEC), a life-threatening intestinal condition, compared to those exclusively fed breast milk.
In fact, a 2021 study highlights that cow’s milk formula fed infants had a markedly higher risk of developing NEC
Unlike breast milk, which offers protective elements like antibodies and bioactive compounds, cow’s milk can lead to inflammation and bacterial overgrowth in the fragile intestines of premature babies.
This toxicity stems from the body’s inability to properly process cow’s milk proteins, triggering the damaging effects of NEC.

The same study concludes that the best milk for premature babies is still human milk.
Given this evidence, the manufacturers of potentially dangerous baby formula may face liability for knowingly marketing these products without adequately warning parents and healthcare providers about the risks associated with their use in preterm infants.
Families affected may be eligible to file NEC formula lawsuits against Abbott, Mead Johnson, or potentially other baby formula manufacturers, asserting that these companies placed profits over safety by continuing to promote their cow’s milk-based formulas despite the known risks.
TorHoerman Law has represented families in NEC baby formula litigation involving cow’s milk-based formulas administered to premature infants.
Claims in the broader NEC litigation have involved Similac products manufactured by Abbott Laboratories and Enfamil products manufactured by Mead Johnson.
The cow’s milk-based formulas named in the NEC Infant Formula Lawsuits are medically administered to premature infants in neonatal intensive care units (NICUs) and maternity wards.
These premature infant formulas are often given to infants as part of their care regimen, particularly when they are born prematurely and require additional nutrients.
However, they are not available for sale in regular retail stores, as they are specifically used in a hospital setting under the supervision of medical professionals.
The key issue at hand is that these medically administered formulas are associated with a higher risk of NEC in vulnerable preterm infants.
Hospitals use these cow’s milk based baby formulas with the belief that they provide the necessary nutritional support for premature babies.
However, concerns have arisen due to studies that show a strong correlation between cow’s milk-based formulas and the development of NEC, particularly in infants who are already at higher risk due to their early birth.
Families affected by NEC after their child was fed these formulas are pursuing lawsuits, arguing that the manufacturers did not provide adequate warnings about the potential dangers associated with these products.

As this litigation progresses, it highlights the importance of fully understanding the risks tied to hospital-administered nutrition for vulnerable newborns.
Understanding the scope of the NEC Lawsuits can shed light on the broader conversation around neonatal care and the potential long-term health impacts of decisions made in the NICU.
Families who have experienced the devastating effects of NEC are calling for accountability from the companies involved.
Similac formulas, produced by Abbott Laboratories, are widely used in hospitals, particularly in neonatal intensive care units (NICUs), to provide essential nutrition to premature and low birth weight infants.
These formulas are not available for purchase in stores and are specifically marketed to hospitals for use in medically fragile infants who require specialized nutrition.
Abbott Laboratories distributes Similac products to healthcare facilities, emphasizing their use in supporting infant growth and development, especially when breast milk is unavailable or insufficient.
However, concerns have been raised about the potential dangers these cow’s milk-based formulas may pose to premature infants, particularly the increased risk of developing necrotizing enterocolitis (NEC).
Similac Baby Formula Lawsuits have focused on the lack of adequate warnings about these risks, arguing that Abbott Laboratories failed to properly inform healthcare providers and parents about the potential dangers.

Similac Infant Formulas mentioned in the NEC Lawsuits include:
Enfamil formulas, manufactured by Mead Johnson & Company, are widely used in neonatal intensive care units (NICUs) and maternity wards to nourish premature and low birth weight infants.
These formulas are not sold in stores but are distributed directly to hospitals, where they are marketed as providing essential nutrition to vulnerable newborns.
Mead Johnson emphasizes the role of Enfamil in promoting growth and development, particularly for infants who cannot rely solely on breast milk.
However, recent concerns have arisen regarding the safety of cow’s milk-based formulas like Enfamil, especially their potential link to necrotizing enterocolitis (NEC).
The Enfamil Baby Formula Lawsuits argue that Mead Johnson did not adequately warn medical providers and parents about the increased risk of NEC in premature infants fed these formulas.

Enfamil Baby Formula products mentioned in the NEC Lawsuits include:
You may be eligible for an Enfamil NEC lawsuit if your child was diagnosed with necrotizing enterocolitis after receiving an Enfamil cow’s milk-based formula or fortifier.
Be sure to learn about the civil litigation process and file within your state’s statute of limitations.

TorHoerman Law is currently accepting new NEC clients with claims involving Enfamil products manufactured by Mead Johnson.
TorHoerman Law is no longer accepting NEC clients with claims against Similac.
Families with potential Enfamil NEC claims can contact our law firm for a free, no-obligation consultation.
Hiring the right personal injury lawyer is essential in ensuring that you get the most out of your case.
Experienced infant formula lawyers will help assess and build your case, litigate your lawsuit, and get rightful compensation for your injuries.
In a personal injury case, such as a NEC infant formula lawsuit, you might be wondering how much it costs to hire an experienced lawyer.
Contingency fees can be utilized in the instance where you cannot pay for an attorney, but are in need of one.
TorHoerman Law operates on a contingency fee basis, which means you do not pay for legal representation unless you receive financial compensation for your case.
Contingency fee agreements can be incredibly helpful in ensuring that you get proper representation regardless of your current financial situation.
You must compile adequate evidence supporting your personal injury case.
Strong evidence can greatly increase your chances of reaching a solid settlement.

Possible evidence for NEC Infant Formula Lawsuits can include:
Your attorney will also help in the process of gathering evidence to build your potential baby formula lawsuit.
Damages are the total amount the defendant is liable to compensate for injuries.
A premature child that contracted NEC is an instance where assessing economic damages should be straightforward.

In NEC Baby Formula Lawsuits, the defendant may be liable to pay for:
For toxic baby formula lawsuits, types of damages you may look for are medical expenses, pain and suffering, permanent disability, and future medical expenses.
Your NEC Baby Formula Lawyers will help you through this step in the process of filing a lawsuit.
To learn more about assessing damages, refer to our guide on personal injury damages.
If your child developed necrotizing enterocolitis (NEC) after receiving an Enfamil formula or fortifier in a hospital or NICU, you may be eligible to file an Enfamil NEC lawsuit.
TorHoerman Law is no longer accepting NEC clients with claims against Similac.
We are still accepting clients with claims against Enfamil. You can use the chatbot on this page to request a free case evaluation.
TorHoerman Law is a personal injury law firm dedicated to fighting for individuals injured at no fault of their own.
TorHoerman Law has represented families in NEC baby formula litigation and is currently accepting new Enfamil NEC claims.
Our law firm handles NEC claims on a contingency fee basis, meaning clients do not pay attorney fees unless compensation is recovered.

Contact TorHoerman Law for a free consultation about a potential Enfamil NEC claim.
Necrotizing enterocolitis is a gastrointestinal disease that almost exclusively affects infants born before the 37th week of pregnancy (premature babies).
NEC creates intestinal inflammation, causing cells to die and holes to form.
This then allows harmful and potentially deadly bacteria to leak in and infect the intestines.
See this page for a list of Common NEC Symptoms in Babies.
Similac and Enfamil baby formulas are mentioned in lawsuits filed against infant formula manufacturers Abbott and Mead Johnson.
The formulas mentioned in the Baby Formula NEC Lawsuits include:
You may qualify for an Enfamil NEC lawsuit if your child was born prematurely, received an Enfamil cow’s milk-based formula or fortifier in a neonatal intensive care unit (NICU) or maternity ward, and was later diagnosed with necrotizing enterocolitis (NEC).
Medical and feeding records may document the specific Enfamil product administered, the timing of formula exposure, the NEC diagnosis, and the treatment or complications that followed.
Filing deadlines vary by state, so the statute of limitations may also affect whether a claim can be pursued.
TorHoerman Law is no longer accepting NEC clients with claims against Similac. We are still accepting clients with claims against Enfamil.
Contact our law firm for a free consultation about a potential Enfamil NEC claim.
The NEC Infant Formula Lawsuit is currently consolidated into multidistrict litigation (MDL) in federal court, while some cases are being handled individually in state courts.
NEC Lawsuits are filed against major baby formula manufacturers, including Abbott Laboratories (Similac) and Mead Johnson (Enfamil), claiming that their cow’s milk-based formulas increase the risk of NEC in premature infants.
Recently, TorHoerman Law secured a landmark $495 million verdict against Abbott Laboratories, which has set a precedent for future NEC lawsuits.
This litigation is ongoing, with more cases being filed as awareness of the risks associated with cow’s milk-based formulas continues to grow.
Settlements may vary based on the severity of the injury and other case-specific factors.
The NEC Baby Formula lawsuits are consolidated into a multidistrict litigation (MDL) to streamline the pretrial process for similar cases.
In the MDL, individual cases are grouped together in federal court to handle common issues such as discovery and pretrial motions.
Unlike a class action lawsuit, where a single case represents an entire group, each plaintiff in the MDL maintains an individual case and may receive compensation based on their unique circumstances.
The MDL is overseen by a single federal judge in the Northern District of Illinois.
The first bellwether trials, which are test cases that help predict outcomes for future cases, are scheduled to take place in 2025.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Toxic Baby Formula NEC Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.